New York, New York (PRWEB) April 11, 2012
Bernstein Liebhard LLP reports that on April 2, 2012, the U.K.’s Medicines and Healthcare products Regulatory Agency (“MHRA”) called for a ban on combining certain metal-on-metal hip replacement parts.* Specifically, the hip replacement warning urged surgeons to stop using a combination of Mitch TRH cup/heads made by Johnson & Johnson subsidiary, Finsbury Orthopaedics, and Accolade femoral stems made by Stryker.* As reported by Bloomberg News, the hip replacement warning issued by the MHRA said that surgeons should stop using these metal-on-metal hip replacement parts together because of “unacceptably high” rates of revision surgeries. The MHRA found that when these particular hip replacement parts are used together, after four years, 10.7 percent of patients required a second operation.
Safety Of Hip Replacement Parts To Be Reviewed At Upcoming FDA Meeting
Following the August 2010 hip implant recall issued by Johnson & Johnson of its ASR implant devices, metal hips have been the subject of widespread criticism and media attention.** As noted by Bloomberg News, researchers have found that metal hip replacement parts have high failure rates and put patients at an increased risk of exposure to toxic materials. In light of these concerns, on March 29, 2012, the U.S. Food and Drug Administration (“FDA”) announced that an advisory panel will convene on June 27-28 to conduct an expert review of metal hip replacement parts.*** As reported by Reuters, a team of scientists, researchers, patients and medical providers will meet to discuss whether to issue a recommendation that new pre-market testing standards and review requirements should be imposed before a medical device can be sold in the United States. According to Reuters, the FDA meeting will focus on “failure rates, metal ion testing, imaging methods, patient risk factors, follow-up surgery and complications associated with metal-on-metal hip replacement and resurfacing systems.”
Latest Hip Replacement Warning Is One In A Series Of Many
The MHRA hip replacement warning is the latest blow to artificial implant systems using metal hip replacement parts. In March 2012, The Lancet, a British medical journal, concluded that metal hip replacement parts are more likely to fail than other artificial hip devices, and should therefore be banned.**** Earlier this year, the MHRA issued a hip replacement warning, advising patients to undergo annual testing for as long as they have a metal-on-metal device to ensure that they are not suffering from tissue damage or other complications.*****
The DePuy hip replacement lawyers at Bernstein Liebhard LLP are actively filing cases on behalf of individuals who have been implanted with metal-on-metal hip replacement parts manufactured by DePuy in the following actions: In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), which is pending in the U.S. District Court for the Northern District of Ohio and In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”), which is pending in the U.S. District Court for the Northern District of Texas. The lawsuits allege that the ASR hip replacement and the metal-on-metal Pinnacle hip replacement systems were defectively designed. The firm is also investigating cases concerning another metal-on-metal hip replacement manufactured by Wright Medical Technology, Inc. Lawsuits involving these metal-on-metal hip replacement parts were recently consolidated in In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation (“MDL No. 2329”), which is pending in the U.S. District Court for the Northern District of Georgia. Like the DePuy litigations, the Wright Medical hip lawsuits allege that the metal-on-metal Wright Conserve hip replacement parts were defectively designed.
For more information about filing a hip replacement lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at info(at)consumerinjurylawyers.com.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP